GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Ccna2 | affects expression | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | Doxorubicin affects the expression of CCNA2 protein | PMID:16036217 | Ccna2 | decreases expression | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | Doxorubicin results in decreased expression of CCNA2 mRNA | PMID:15205334 PMID:29803840 PMID:30031762 PMID:30581319 | Ccna2 | increases expression | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | Doxorubicin results in increased expression of CCNA2; Doxorubicin results in increased expression of CCNA2 protein | PMID:16284694 PMID:22751436 | Ccna2 | multiple interactions | ISO | CCNA2 (Homo sapiens) | 6480464 | CTD | [Folic Acid co-treated with Doxorubicin] results in decreased expression of CCNA2 mRNA; Doxorubicin affects the expression of and affects the localization of CCNA2 protein; Doxorubicin promotes the reaction [RBL2 protein binds to CCNA2 promoter]; palbociclib inhibits the reaction [Doxorubicin results in increased expression of CCNA2 protein]; RB1 protein affects the reaction [palbociclib inhibits the reaction [Doxorubicin results in increased expression of CCNA2 protein]] | PMID:16537896 PMID:17390037 PMID:22751436 PMID:30581319 | |
Go Back to source page | Continue to Ontology report |